| 1 | Study | 1.38% | |
| 2 | COVID-19 | 0.9% | |
| 3 | New | 0.83% | |
| 4 | Medicina | 0.83% | |
| 5 | Health | 0.62% | |
| 6 | Risk | 0.62% | |
| 7 | AI | 0.48% | |
| 8 | Hospital | 0.48% | |
| 9 | UK | 0.48% | |
| 10 | Patients | 0.48% | |
| 11 | Asia | 0.41% | |
| 12 | Cancer | 0.41% | |
| 13 | May | 0.41% | |
| 14 | Covid | 0.41% | |
| 15 | Brain | 0.41% | |
| 16 | Heart | 0.35% | |
| 17 | mRNA | 0.35% | |
| 18 | Gene | 0.35% | |
| 19 | Salud | 0.35% | |
| 20 | Degeneration | 0.35% | |
| 21 | Researchers | 0.28% | |
| 22 | Review | 0.28% | |
| 23 | Management | 0.28% | |
| 24 | Alzheimer’s | 0.28% | |
| 25 | Therapy | 0.28% | |
| 26 | Macular | 0.28% | |
| 27 | Report | 0.28% | |
| 28 | Case | 0.28% | |
| 29 | China | 0.28% | |
| 30 | US | 0.28% | |
| 31 | COVID | 0.21% | |
| 32 | Anvisa | 0.21% | |
| 33 | Treatment | 0.21% | |
| 34 | Alzheimers | 0.21% | |
| 35 | Pandemic | 0.21% | |
| 36 | Biomarker | 0.21% | |
| 37 | Boosts | 0.21% | |
| 38 | Association | 0.21% | |
| 39 | Genetic | 0.21% | |
| 40 | Syndrome | 0.21% | |
| 41 | COPD | 0.21% | |
| 42 | Breakthrough | 0.21% | |
| 43 | Mounjaro | 0.21% | |
| 44 | Exercise | 0.21% | |
| 45 | Taurine | 0.21% | |
| 46 | Patient | 0.21% | |
| 47 | Disease | 0.21% | |
| 48 | QA | 0.21% | |
| 49 | GLP-1 | 0.21% | |
| 50 | Prostate | 0.21% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Optimal Treatment Strategies for De Novo Metastatic Hormone-Sensitive Prostate Cancer - Neal Shore
UroToday
2025-06-06 05:01:55
Adam Weiner, MD, on therapeutic decision-making in metastatic prostate cancer
Urology Times
2025-06-06 03:44:07
Prostate Test Enhanced with New Insights for Higher Risk Patients
Imaging Technology News
2025-06-06 03:11:58
Urology Times
2025-06-05 23:59:05